Sign in
4

Changes in Ownership

Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000096

Chairman and CMO bought 27,500 shares at an average $1.83 ($50,359)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kim Christopher Chairman and CMO 2025-05-13 Purchase +19,770 $1.82 $35,981 19,770 D
Kim Christopher Chairman and CMO 2025-05-14 Purchase +7,730 $1.86 $14,378 27,500 D
Open-market purchases · 27,500 sh · avg $1.83 · $50,359
Loading xslF345X05/primary_doc.xml…